Suppr超能文献

阿片类物质使用障碍药物辅助治疗报告要求。最终规则。

Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements. Final rule.

出版信息

Fed Regist. 2016 Sep 27;81(187):66191-6.

Abstract

This final rule outlines annual reporting requirements for practitioners who are authorized to treat up to 275 patients with covered medications in an office-based setting. This final rule will require practitioners to provide information on their annual caseload of patients by month, the number of patients provided behavioral health services and referred to behavioral health services, and the features of the practitioner's diversion control plan. These reporting requirements will help the Department of Health and Human Services (HHS) ensure compliance with the requirements of the final rule, "Medication Assisted Treatment for Opioid Use Disorders," published in the Federal Register on July 8, 2016.

摘要

本最终规则概述了在基于办公室的环境中被授权使用涵盖药物治疗多达275名患者的从业者的年度报告要求。本最终规则将要求从业者按月提供其患者年度病例量、接受行为健康服务和被转介至行为健康服务的患者数量,以及从业者转移控制计划的特征等信息。这些报告要求将有助于卫生与公众服务部(HHS)确保遵守于2016年7月8日在《联邦公报》上发布的最终规则“阿片类物质使用障碍的药物辅助治疗”的要求。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验